๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex

โœ Scribed by Benjamin J. McFarland; Craig Beeson


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
464 KB
Volume
22
Category
Article
ISSN
0198-6325

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

The activation of helper T cells by peptides bound to proteins of the class II Major Histocompatibility Complex (MHC II) is pivotal to the initiation of an immune response. The primary functional requirement imposed on MHC II proteins is the ability to efficiently bind thousands of different peptides. Structurally, this is reflected in a unique architecture of binding interactions. The peptide is bound in an extended conformation within a groove on the membrane distal surface of the protein that is lined with several pockets that can accommodate peptide sideโ€chains. Conserved MHC II protein residues also form hydrogen bonds along the length of the peptide mainโ€chain. Here we review recent advances in the study of peptideโ€MHC II protein reactions that have led to an enhanced understanding of binding energetics. These results demonstrate that peptideโ€MHC II protein complexes achieve high affinity binding from the array of hydrogen bonds that are energetically segregated from the pocket interactions, which can then add to an intrinsic hydrogen bondโ€mediated affinity. Thus, MHC II proteins are unlike antibodies, which utilize cooperativity among binding interactions to achieve high affinity and specificity. The significance of these observations is discussed within the context of possible mechanisms for the HLAโ€DM protein that regulates peptide presentation in vivo and the design of nonโ€peptide molecules that can bind MHC II proteins and act as vaccines or immune modulators. ยฉ 2002 John Wiley & Sons, Inc. Med Res Rev, 22, No. 2, 168โ€“203, 2002; DOI 10.1002/med.10006


๐Ÿ“œ SIMILAR VOLUMES


Regulation of peptide presentation by ma
โœ Alexei von Delwig; Julieโ€„A. Musson; Norman McKie; Joe Gray; Johnโ€„H. Robinson ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 283 KB

We studied major histocompatibility complex class II-dependent presentation of two T cell epitopes delivered as synthetic peptides by fixed macrophages. Treatment of bone marrow macrophages with inhibitors of proteinases of the metallo-, aspartic and serine proteinase families enhanced presentation